| Cash Flow | 2025-07-31 |
|---|---|
| Loss on disposal of equipment | -20 |
| Net (loss) income | -466 |
| Stock-based compensation | 208 |
| Depreciation and amortization expense | 358 |
| Operating lease right-of use assets | 310 |
| Allowance and estimated credit losses | -29 |
| Accounts receivable | -1,759 |
| Prepaid expenses and other current assets | -154 |
| Accounts payable | 411 |
| Accrued liabilities | -755 |
| Operating lease liabilities | -356 |
| Deferred revenue | -1,014 |
| Net cash provided by operating activities | 600 |
| Purchase of property and equipment | 46 |
| Net cash used in investing activities | -46 |
| Proceeds from exercise of options | 24 |
| Finance lease payments | 38 |
| Net cash used in financing activities | -14 |
| Increase in cash | 540 |
CHAMPIONS ONCOLOGY, INC. (CSBR)
CHAMPIONS ONCOLOGY, INC. (CSBR)